Multiple Sclerosis Clinical Trials in New York

Showing 741-760 of 812 trials

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

NCT00076011

The primary purpose of this protocol is to determine the activity of AG 013736 in patients with metastatic renal cell cancer who have received 1 prior cytokine-based therapy.

Kidney Neoplasms

Pfizer52 participantsStarted Oct 2003

San Francisco, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +6 more locations

COMPLETEDPhase 3< 1 mile

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

NCT00649792

The purpose of the study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months in patients who previously participated in the MS-F204 study or until it becomes commercially available, whichever comes first.

Multiple Sclerosis

Acorda Therapeutics214 participantsStarted Aug 2007

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Fayetteville, Arkansas, United States +39 more locations

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

Multiple Sclerosis Trials in Other Cities

Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy

Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer

TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer

Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

EPO906 Therapy in Patients With Advanced Kidney Cancer

A Study of MF101 in Postmenopausal Women

Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

Effect of Cabazitaxel on the QTc Interval in Cancer Patients

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies

Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Other Conditions in New York